Corvus Pharmaceuticals to Present at the 35th Annual J.P.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
120
Corvus Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference 2017

BURLINGAME, Calif., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today announced that the company will present at the 35 th Annual J.P. Morgan Healthcare Conference 2017 in San Francisco. The presentation is scheduled for Thursday, January 12, at 8:00 a.m. Pacific Time.

A webcast of the presentation will be available live and for 7 days following the event. The webcast may be accessed via the conference direct link and from the investor relations section of Corvus’ website.

 About Corvus Pharmaceuticals Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of small molecule and antibody agents that target the immune system to treat patients with cancer. These agents block or modify crucial immune checkpoints and reprogram immune T-cells. Corvus’ lead product, CPI-444, is a checkpoint inhibitor that is designed to disable a tumor’s ability to subvert attack by the immune system by inhibiting adenosine in the tumor microenvironment. CPI-444 is a small molecule that is taken orally. CPI-444 is currently being evaluated in a multicenter Phase 1/1b clinical trial in patients with various solid tumors. This successive expansion cohort trial is examining the activity of CPI-444 both as a single agent and in combination with Genentech’s Tecentriq® (atezolizumab), an anti-PD-L1 antibody. Corvus is conducting the trial with Genentech, a member of the Roche Group, under a clinical trial collaboration the two companies entered into in October 2015. For more information, visit: www.corvuspharma.com .

Corvus Contact: Jason Coloma SVP, Chief Business Officer   Corvus Pharmaceuticals, Inc. 650-900-4511 jcoloma@corvuspharma.com Media Contact: Julie Normart BrewLife +1-415-946-1087 jnormart@brewlife.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 173

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 234

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 195

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 372

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 113

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 115

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

SharpLink Gaming Begins Options Trading on Nasdaq - A New Era

Updated Category News Views 269

Exciting Developments at SharpLink Gaming SharpLink Gaming, Inc. (Nasdaq: SBET), a leader in the gaming and sports betting industry, has just unveiled a significant milestone. Recently, the Company received approval for options trading on the Nasdaq Options Market. This news comes as SharpLink continues to establish its reputation, now recognized as the largest publicly...

Continue Reading
Global Gold Trading Contest Set to Engage Thousands of Traders

Updated Category News Views 189

FastBull Unveils the 2026 GOLD Global S1 Demo Trading Contest The financial world is buzzing as FastBull announces the commencement of the 2026 FastBull GOLD Global S1 Demo Trading Contest, a thrilling competition set against the backdrop of gold trading. This global trading contest invites traders from across the world to participate, promising excitement and engagement....

Continue Reading
Cardlytics, Inc. (CDLX) Investors Urged to Seek Legal Help

Updated Category News Views 113

Urgent Notice for Cardlytics, Inc. Investors The Law Offices of Howard G. Smith is reaching out to encourage all investors who purchased shares of Cardlytics, Inc. (CDLX) to consider participating in a class action lawsuit. This lawsuit addresses potential securities fraud that may have affected your investments. Details of the Class Action Cardlytics investors have until...

Continue Reading
Shanghai's Vision for a Vibrant Business Future

Updated Category News Views 154

Shanghai's Vision for a Vibrant Business Future Recently, Shanghai made headlines with its ambitious new action plan aimed at enhancing its business environment. This plan builds on the city’s previous achievements, where it already excels in 22 World Bank indicators that measure the effectiveness of business ecosystems. Accelerating Economic Development The action plan...

Continue Reading
Premium Service Brands Launches Innovative Nesto Platform

Updated Category News Views 661

Premium Service Brands Introduces Nesto, a Game-Changer Premium Service Brands (PSB) has recently unveiled its new all-in-one home services platform, Nesto, aimed at enhancing customer relationships and improving operational efficiency for franchisees. This innovative service debuted in Denver, making it easier for homeowners to find the services they need in a single,...

Continue Reading